scispace - formally typeset
T

Teresa R. Ward

Researcher at Merck & Co.

Publications -  5
Citations -  8881

Teresa R. Ward is an academic researcher from Merck & Co.. The author has contributed to research in topics: Gene & Genome. The author has an hindex of 4, co-authored 5 publications receiving 8426 citations.

Papers
More filters
Journal ArticleDOI

Functional profiling of the Saccharomyces cerevisiae genome.

Guri Giaever, +72 more
- 25 Jul 2002 - 
TL;DR: It is shown that previously known and new genes are necessary for optimal growth under six well-studied conditions: high salt, sorbitol, galactose, pH 8, minimal medium and nystatin treatment, and less than 7% of genes that exhibit a significant increase in messenger RNA expression are also required for optimal Growth in four of the tested conditions.
Journal ArticleDOI

Functional Characterization of the S. cerevisiae Genome by Gene Deletion and Parallel Analysis

TL;DR: A total of 6925 Saccharomyces cerevisiae strains were constructed, by a high-throughput strategy, each with a precise deletion of one of 2026 ORFs (more than one-third of the ORFs in the genome), finding that 17 percent were essential for viability in rich medium.
Journal ArticleDOI

Widespread aneuploidy revealed by DNA microarray expression profiling.

TL;DR: The general usefulness of expression profiles for nearly 300 Saccharomyces cerevisiae deletion mutants, obtained recently, is demonstrated, with implications for interpreting whole-genome expression data, particularly from cells known to suffer genomic instability, such as malignant or immortalized cells.
Journal ArticleDOI

Chromosome 20q Amplification Regulates in Vitro Response to Kinesin-5 Inhibitor

TL;DR: The results suggest that patients whose tumors overexpress AurKA due to amplification of 20q will more likely resist treatment with Kinesin-5 inhibitor, and that inactivation of AURKA may sensitize these patients to treatment.
Patent

LXR-ligand induced genes and proteins

TL;DR: In this paper, the LXR-Ligand Induced I (LXRLI1) gene expression profile was used to diagnose a disease or disorder involving LXR activity, screen for compounds that change the activity of LXR and to classify LXR ligands.